Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1726-1736

  Linton, MacRae F ^a,b   Hasty, Alyssa H ^a   Babaev, Vladimir R ^a   Fazio, Sergio ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN HEART ASSOCIATION   (United States)

Author keywords

Bone marrow transplantation; Dyslipidemia; Gene delivery; Macrophages; Mouse models

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RELATED PROTEIN; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; LIPOPROTEIN BLOOD LEVEL; LIVER CLEARANCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032523099     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2181     Document Type: Article

References (42)

1. Mahley, R.W., and M.M. Hussain. 1991. Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2:170-176.
2. Schaefer, E.J., R.E. Gregg, G. Ghiselli, T.M. Forte, J.M. Ordovas, L.A. Zech, and H.B. Brewer, Jr. 1986. Familial apolipoprotein E deficiency. J. Clin. Invest. 78:1206-1219.
3. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
4. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
5. Rubinsztein, D.C., J.C. Cohen, G.M. Berger, D.R. van der Westhuyzen, G.A. Coetzee, and W. Gevers. 1990. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J. Clin. Invest. 86:1306-1312.
6. Kita, T., J.L. Goldstein, M.S. Brown, Y. Watanabe, C.A. Hornick, and R.J. Havel. 1982. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 79:3623-3627.
7. Ishibashi, S., M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
8. Choi, S.Y., L.G. Fong, M.J. Kirven, and A.D. Cooper. 1991. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88:1173-1181.
9. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K.K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341:162-164.
10. Willnow, T.E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264:1471-1474.
11. Rohlmann, A., M. Gotthardt, R.E. Hammer, and J. Herz. 1998. Inducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101:689-695.
12. Havel, R.J. 1995. Chylomicron remnants: hepatic receptors and metabolism. Curr. Opin. Lipidol. 6:312-316.
13. Mahley, R.W. 1996. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr. J. Med. Sci. 32:414-129.
14. Ji, Z.-S., W.J. Brecht, R.D. Miranda, M.M. Hussain, T.L. Innerarity, and R.W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160-10167.
15. Ji, Z.-S., S. Fazio, Y.-L. Lee, and R.W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269:2764-2772.
16. Shafi, S., S.F. Brady, A. Bensadoun, and R.J. Havel. 1994. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35:709-720.
17. Brasaemic, D.L., K. Cornely-Moss, and A. Bensadoun. 1993. Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J. Lipid Res. 34:455-465.
18. Kowal, R.C., J. Herz, J.L. Goldstein, V. Esser, and M.S. Brown. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:5810-5814.
19. Hamilton, R.L., J.S. Wong, L.S.S. Guo, S. Krisans, and R.J. Havel. 1990. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid Res. 31:1589-1603.
20. Weisgraber, K.H., R.W. Mahley, R.C. Kowal, J. Herz, J.L. Goldstein, and M.S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoprotein (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:22453-22459.
21. Brown, M.S., J. Herz, R.C. Kowal, and J.L. Goldstein. 1991. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2:65-72.
22. Shimano, H., Y. Namba, J. Ohsuga, M. Kawamura, K. Yamamoto, M. Shimada, T. Gotoda, K. Harada, Y. Yazaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93:2215-2223.
23. Linton, M.F., R. Gish, S.T. Hubl, E. Bütler, C. Esquivel, W.I. Bry, J.K. Boyles, M.R. Wardell, and S.G. Young. 1991. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88:270-281.
24. Basu, S.K., M.S. Brown, Y.K. Ho, R.J. Havel, and J.L. Goldstein. 1981. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc. Natl. Acad. Sci. USA. 78:7545-7549.
25. Linton, M.F., J.B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apoE deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
26. Ishibashi, S., J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knock-out" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl. Acad. Sci. USA. 91:4431-4435.
27. Fazio, S., A.H. Hasty, K.J. Carter, A.B. Murray, J.O. Price, and M.F. Linton. 1997. Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J. Lipid Res. 38:391-400.
28. Fazio, S., Y.-L. Lee, Z.-S. Ji, and S.C. Rall, Jr. 1993. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J. Clin. Invest. 92:1497-1503.
29. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
30. McFarlane, A.S. 1958. Efficient trace-labeling of proteins with iodine. Nature. 132:53.
31. Bilheimer, D.W., S. Eisenberg, and R.I. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260:212-221.
32. 2-macroglobulin receptor. J. Biol. Chem. 266:13936-13940.
33. Herz, J., and R.D. Gerard. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:2812-2816.
34. Fazio, S., V.R. Babaev, A.B. Murray, A.H. Hasty, K.J. Carter, L.A. Gleaves, J.B. Atkinson, and M.F. Linton. 1997. Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages. Proc. Natl. Acad. Sci. USA. 94:4647-1652.
35. Boisvert, W. A., J. Spangerberg, and L.K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96:1118-1124.
36. Fazio, S., and M.F. Linton. 1996. Murine bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism and atherogenesis. Trends Cardiovasc. Med. 6:58-65.
37. Kashyap, V., S. Santamarina-Fojo, D. Brown, D. Applebaum-Bowden, S. Meyn, C. Parrott, N. Maeda, and J.H.B. Brewer. 1994. ApoE deficiency: gene replacement using adenovirus vectors. Circulation. 90:I-134.
38. Herz, J., S.-Q. Qiu, A. Oesterle, H.V. DeSilva, S. Shafi, and R.J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:4611-1615.
39. Mortimer, B.-C., D.J. Beveridge, I.J. Martins, and T.G. Redgrave. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway. J. Biol. Chem. 270:28767-28776.
40. Kuchenhoff, A., B. Harrach-Ruprecht, and H. Robenek. 1997. Interaction of apoE-containing lipoproteins with the LDL receptor-related protein LRP. Am. J. Physiol. 272(Cell. Physiol. 41):C369-C382.
41. Willnow, T.E., S.A. Armstrong, R.E. Hammer, and J. Herz. 1995. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. Natl. Acad. Sci. USA. 92: 4537-4541.
42. Willnow, T.E., A. Rohlmann, J. Horton, H. Otani, J.R. Braun, R.E. Hammer, and J. Herz. 1996. RAP, a specialized chaperone, prevents ligand induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO (Eur. Mol. Biol. Organ.) J. 15:2632-2639.